Publicaciones (22) Publicaciones de MIGUEL ARIAS GUILLEN

2022

  1. Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 649-659

  2. Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content

    The European respiratory journal, Vol. 60, Núm. 1

  3. Methotrexate in interstitial lung disease associated with rheumatoid arthritis

    Reumatologia Clinica

2021

  1. Acquisition of new migratory properties by highly differentiated cd4+cd28null t lymphocytes in rheumatoid arthritis disease

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  2. Assessment of risk scores in Covid-19

    International Journal of Clinical Practice, Vol. 75, Núm. 12

  3. Biotrauma during ultra-low tidal volume ventilation and venoarterial extracorporeal membrane oxygenation in cardiogenic shock: a randomized crossover clinical trial

    Annals of Intensive Care, Vol. 11, Núm. 1

  4. Can SARS-CoV-2 be a Risk Factor for Pulmonary Aspergillosis?

    Archivos de Bronconeumologia, Vol. 57, pp. 72-73

  5. New Research Strategies in Latent Tuberculosis Infection

    Archivos de Bronconeumologia

2020

  1. Clinical impact of a pleural unit in a tertiary level hospital

    Archivos de Bronconeumologia

  2. Impacto clínico de una unidad de patología pleural en un hospital de tercer nivel

    Archivos de bronconeumologia, Vol. 56, Núm. 3, pp. 143-148

  3. Nuevas perspectivas en infección tuberculosa latente

    Archivos de bronconeumologia

  4. Severe asthma and bronchiectasis

    Journal of Asthma, Vol. 57, Núm. 5, pp. 505-509

2019

  1. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59

  2. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

    International Journal of Infectious Diseases, Vol. 83, pp. 72-76

2018

  1. High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 3, pp. 538-546

  2. Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient

    Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 584-601

2016

  1. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment

    Archivos de Bronconeumologia, Vol. 52, Núm. 1, pp. 36-45

2014

  1. Impact of the Xpert® MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 4, pp. 435-437

  2. T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases, Vol. 20, Núm. 2, pp. 329-338

2011

  1. Avances en el diagnóstico de la infección tuberculosa

    Archivos de Bronconeumologia